Cart
sales@molnova.com
Pumecitinib
CAS No. 2401057-12-1
Pumecitinib( —— )
Catalog No. M35964 CAS No. 2401057-12-1
Pumecitinib is a Janus kinase (JAK) inhibitor. Pumecitinib exhibits anti-inflammatory activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 46 | Get Quote |
|
| 5MG | 69 | Get Quote |
|
| 10MG | 112 | Get Quote |
|
| 25MG | 200 | Get Quote |
|
| 50MG | 318 | Get Quote |
|
| 100MG | 444 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePumecitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionPumecitinib is a Janus kinase (JAK) inhibitor. Pumecitinib exhibits anti-inflammatory activity.
-
DescriptionPumecitinib is a Janus kinase (JAK) inhibitor with anti-inflammatory activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2401057-12-1
-
Formula Weight400.46
-
Molecular FormulaC17H20N8O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (312.14 mM; Ultrasonic (<60°C)
-
SMILESCC(C)S(=O)(=O)N1CC(CC#N)(C1)n1cc(c(N)n1)-c1ncnc2[nH]ccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. WHO Drug Information-World Health Organization (WHO).
molnova catalog
related products
-
Sweroside
Sweroside is a promising osteoporosis therapeutic natural product, has anti-osteoporotic effect on the human MG-63 cells and rat osteoblasts.
-
S-Ruxolitinib
Ruxolitinib (INCB018424) is the first potent selective JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays.
-
LY2784544
LY2784544 (Gandotinib) is a potent, selective and ATP-competitive inhibitor of JAK2V617F.
